口腔抗凝固療法を受けている患者の知識と知識に影響を与える要因の評価
Janet Prameela Dsouza1, Jyothi Chakrabarty1, Padmakumar Ramachandran2
1Department of Medical Surgical Nursing, Manipal College of Nursing, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Hospital topics
|February 19, 2026
まとめ
ビタミンKアンタゴニスト (VKA) を服用しているほとんどの患者は,特に食事,薬物相互作用,および副作用に関して,経口抗凝固薬に関する知識が不足しています. 標的を絞った教育は,治療の安全性と効果を向上させるために極めて重要です.
科学分野:
- 薬理学 薬理学とは
- 患者教育についてです.
- 公衆衛生は公衆衛生である.
背景:
- ビタミンKアンタゴニスト (VKA) は,心房動などの疾患において,血栓性イベントを予防するために極めて重要です.
- VKAの管理は,その狭い治療範囲と出血リスクに影響を与える要因のために困難です.
- 経口抗凝固療法に関する知識不足は,治療の有効性と安全性を損なう可能性があります.
研究 の 目的:
- 口服抗凝固療法に関する患者の知識を評価する.
- インドの南カルナタカ州の都市部と農村部で,この知識に影響を与える要因を特定する.
主な方法:
- 横断的な調査デザインが採用されました.
- VKAを受けた320人の患者が参加した.
- データは,抗凝固知識アンケートを使用して収集されました.
主要な成果:
- ほとんどの患者は,特に食事,薬物相互作用,薬剤の副作用に関する口腔抗凝固薬の知識が乏しいことを示しました.
- 知識は,実験室モニタリングに関して最も高く,薬剤管理に関して中等でした.
- 高等教育,事前の教育セッション,およびより長い治療期間は,よりよい知識と関連していました.
結論:
- 患者知識の評価は,対象となる教育的介入の開発に不可欠です.
- 口服抗凝固薬に対する患者の理解を向上させることで,合併症を予防し,生活の質を向上させることができます.
関連する概念動画
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.5K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.5K
Venous Thrombosis III: Interprofessional Care
392
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
392
Venous Thrombosis IV: Nursing Management
283
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
283
Therapeutic Drug Monitoring: Affecting Factors
258
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
258
Factors Affecting Protein-Drug Binding: Patient-Related Factors
354
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
354
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.0K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.0K


